Source: Business Insider
Summary
Naveen Jain’s longevity startup Viome acquired Biograph, a medical testing company co-founded by Attia, which came out of stealth a year ago. The acquisition aims to enhance Viome’s health testing capabilities. Attia will join Viome’s board of directors. Biograph’s technology focuses on analyzing biological markers to predict and prevent chronic diseases.
Our Reading
The acquisition follows a familiar script.
Viome buys Biograph, a startup that’s been around for a year, to boost its health testing capabilities. Because what the world really needed was another longevity startup with a fancy new board member. And by “breakthrough,” we mean “more data to sell.” Biograph’s “innovative” approach to analyzing biological markers is just a fancy way of saying “we’re trying to predict disease with math.” Meanwhile, the real innovation is in the press release.
Author: Evan Null
